Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5220655

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CO[C@H]1C=C2[C@@H]3C[C@H](C)CC[C@]3(C(=O)O)CC[C@@]2(C)[C@]2(C)CC[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]12

Basic Information

ChEMBL ID CHEMBL5220655
Phase Preclinical
Structure Type MOL
InChI Key WRZHJAAWMAEUES-JRDFMWLBSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

472.7
MW (Da)
6.47
ALogP
3
HBA
2
HBD
66.8
PSA (Ų)
0.45
QED
1
Ro5 Violations
2
Rot. Bonds

Drug Information

Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C30H48O4
MW 472.71
Aromatic Rings 0
Heavy Atoms 34
NP-Likeness 3.25

Activity Summary

IC50 1 meas. best 5.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.4 5.4 4010.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 4010.0 nM 5.4 Inhibition of human carboxylesterase using 4-benzoyl-N-butyl-1,8-naphthalimide a... 33148492

Literature References

PubMed DOI Target Context # Activities
33148492 10.1016/j.ejmech.2020.112960 Unchecked 1

Data from ChEMBL 36 via Core Engine